CD44 and triple-negative breast carcinoma: Based on overexpression and knockdown experiments, it has been shown that TDP43 promotes variant exons inclusion in CD44 mRNA, especially exons v8, v9, and v10, in triple-negative breast cancer cell lines MDA-MB-231 and HCC 1806 (Guo L. et al., 2022).